Filing Details
- Accession Number:
- 0001214659-21-006695
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-17 16:31:07
- Reporting Period:
- 2021-06-15
- Accepted Time:
- 2021-06-17 16:31:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1677077 | Alzamend Neuro Inc. | ALZN | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1212502 | Iii C Milton Ault | 3802 Spectrum Boulevard, Suite 112C Tampa FL 33612 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-06-15 | 2,000,000 | $5.00 | 5,094,555 | No | 4 | P | Indirect | By Digital Power Lending, LLC |
Common Stock | Acquisiton | 2021-06-17 | 15,000,000 | $0.00 | 15,000,000 | No | 4 | C | Indirect | By Ault Life Sciences, Inc. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Digital Power Lending, LLC |
No | 4 | C | Indirect | By Ault Life Sciences, Inc. |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Convertible Preferred Stock | Disposition | 2021-06-17 | 750,000 | $0.00 | 15,000,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 10,000,000 | Indirect | By Ault Life Sciences Fund, LLC |
Footnotes
- Digital Power Lending, LLC ("DPL") is a wholly-owned subsidiary of Ault Global Holdings, Inc. ("AGH"). Mr. Ault, the Executive Chairman of AGH, is deemed to have voting and investment power with respect to the securities held of record by DPL.
- The 15,000,000 shares of Common Stock were issued to Ault Life Sciences, Inc. ("ALS") upon the conversion of the 750,000 shares of the Issuer's Series A Convertible Preferred Stock (the "Series A Preferred Stock") owned by ALS, which conversion occurred automatically upon the closing of the Issuer's initial public offering without payment of further consideration. Mr. Ault has sole voting and investment power with respect to the shares of Series A Preferred Stock held of record by ALS.
- Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.